Medexus Pharmaceuticals Inc.

TSX:MDP Stock Report

Market Cap: CA$38.2m

Medexus Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 3/6

Medexus Pharmaceuticals has a total shareholder equity of $29.6M and total debt of $51.7M, which brings its debt-to-equity ratio to 174.9%. Its total assets and total liabilities are $160.4M and $130.8M respectively. Medexus Pharmaceuticals's EBIT is $12.8M making its interest coverage ratio 0.9. It has cash and short-term investments of $8.2M.

Key information

174.9%

Debt to equity ratio

US$51.70m

Debt

Interest coverage ratio0.9x
CashUS$8.21m
EquityUS$29.56m
Total liabilitiesUS$130.82m
Total assetsUS$160.38m

Recent financial health updates

Recent updates

Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive

Mar 03
Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive

Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story

Jan 06
Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story

Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors

Oct 11
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Sep 11
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky

Jan 19
Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Sep 22
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?

Dec 16
Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?

Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially

Aug 21
Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Aug 04
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Medexus Pharmaceuticals Inc. (CVE:MDP): When Will It Breakeven?

May 04
Medexus Pharmaceuticals Inc. (CVE:MDP): When Will It Breakeven?

The Independent Director of Medexus Pharmaceuticals Inc. (CVE:MDP), Michael Mueller, Just Bought 34% More Shares

Feb 26
The Independent Director of Medexus Pharmaceuticals Inc. (CVE:MDP), Michael Mueller, Just Bought 34% More Shares

Did Business Growth Power Medexus Pharmaceuticals' (CVE:MDP) Share Price Gain of 174%?

Feb 24
Did Business Growth Power Medexus Pharmaceuticals' (CVE:MDP) Share Price Gain of 174%?

Financial Position Analysis

Short Term Liabilities: MDP's short term assets ($74.1M) exceed its short term liabilities ($66.5M).

Long Term Liabilities: MDP's short term assets ($74.1M) exceed its long term liabilities ($64.3M).


Debt to Equity History and Analysis

Debt Level: MDP's net debt to equity ratio (147.1%) is considered high.

Reducing Debt: MDP's debt to equity ratio has increased from 39% to 174.9% over the past 5 years.

Debt Coverage: MDP's debt is well covered by operating cash flow (40.6%).

Interest Coverage: MDP's interest payments on its debt are not well covered by EBIT (0.9x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.